Navigation Links
Discovery in Lungs May Lead to Treatment for Respiratory Virus
Date:12/24/2009

Naturally occurring lipid appears to protect against RSV, research shows

THURSDAY, Dec. 24 (HealthDay News) -- A lipid found in the lungs appears to have the ability to prevent infection with respiratory syncytial virus (RSV), which is a major cause of infection in babies and can also be dangerous for adults with chronic lung diseases and conditions such as HIV, researchers report.

The lipid, known as POPG, seems to help the lungs do a better job of keeping irritants out, according to the new study.

"Our findings demonstrate that POPG is a potent antiviral agent both as a prophylactic and after infection has occurred," said study co-author Dennis Voelker, a professor of medicine at National Jewish Health in Denver. "While these are still early studies, several characteristics of POPG make me believe that it has real potential as both an antiviral and anti-inflammatory treatment."

POPG -- palmitoyl-oleoyl-phosphatidylglycerol -- is found in the fluid that lines the lungs' air sacs. Researchers think they've figured out how it works, and in the new study, they report that it prevents RSV infection in the laboratory.

"Our findings suggest that supplemental POPG may have significant potential for preventing RSV infections in vulnerable human populations and treating infections after they become established," the study authors wrote in their report published in this week's issue of the Proceedings of the National Academy of Sciences.

Voelker and colleagues next want to figure out whether POPG may be an effective treatment for other germs, such as those that cause flu.

More information

For more about respiratory syncytial virus, visit the U.S. Centers for Disease Control and Prevention.



-- Randy Dotinga



SOURCE: National Jewish Medical and Research Center, news release, Dec. 21, 2009


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Gene Discovery Sheds Light on Childrens Asthma
2. Winter Issue of Discoverys Edge
3. Molecule Discovery Might Help ALS Patients
4. Discovery Healths New Year, New You Week Brings Transformation and Inspiration to the Resolution Season
5. Case Western Reserve researchers new pathway discovery published as Paper of the Week
6. New discovery about the formation of new brain cells
7. NCCN Emphasizes Tailored Treatment in Discovery Health Channel Program Metastatic Breast Cancer: Individualizing Treatment
8. Discovery Boosts Boys Prospects for Post-Cancer Fertility
9. SENSA(R) WEIGHT-LOSS PROGRAM: The Accidental Discovery Thats Transforming The Way People Lose Weight Breaks the Top 500 at Amazon.com in Less Than Two Weeks of Publication
10. Gene Discovery Gives Clues to Crohns Disease, Colitis
11. VIA Pharmaceuticals Featured at Cambridge Healthtech Institute Discovery on Target 2009 Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... ... March 23, 2017 , ... The ... from the NCQA. The accreditation covers StayWell’s asthma, coronary artery disease, congestive heart ... granted to organizations that have excellent programs for the delivery and improvement of ...
(Date:3/23/2017)... ... March 23, 2017 , ... March 23, 2017 - ... to easily reprint customer invoices, bills, statements and other correspondence when they have ... needed to retrieve and print the documents and batch them for efficient handling. ...
(Date:3/23/2017)... OR (PRWEB) , ... March 23, 2017 , ... Sharon ... Water, Global Climate Change and Your Health on VoiceAmerica, recently talked on her program ... she also used the occasion to remind listeners of an important distinction. World Water ...
(Date:3/23/2017)... ... March 23, 2017 , ... Corra Group is ... competitive pricing. Verisys through its FACIS and other services maintains the ... actions. , “We are delighted to be able to offer these various products ...
(Date:3/23/2017)... ... March 23, 2017 , ... ... New MEDDEV 2.7/1 Rev. 4 Guidance, **An FDAnews Webinar**, April 4, 2017 ... will the new EU MDR language change the way manufacturers approach CERs? ...
Breaking Medicine News(10 mins):
(Date:3/23/2017)... 23, 2017  Cornerstone Pharmaceuticals, Inc., a ... milestone today.  Following successful End-of-Phase I (EOP1) ... and Drug Administration (FDA), the Company has ... path forward to conduct pivotal trials of ... acute myeloid leukemia (AML) and pancreatic cancer. ...
(Date:3/23/2017)... March 23, 2017 Piramal ... Limited, anuncia el nombramiento de Stuart E. ... plataforma de servicios integrados completa para su base ... cargo clave en el crecimiento y ejecución de ... responsable de impulsar todas las actividades de desarrollo ...
(Date:3/23/2017)... Merrimack Pharmaceuticals, Inc. (NASDAQ: MACK ) ... a Phase 1 study of MM-310 in solid tumors. ... novel taxane and targets the EphA2 receptor, a protein ... major tumor types, including prostate, ovarian, bladder, gastric, pancreatic ... study is an important step in evaluating MM-310,s safety ...
Breaking Medicine Technology: